Home › Products › Rheumatology › Igurati 25mg Tablet
Igurati 25mg Tablet
Salt Composition: IGURATIMOD
- Manufacturer: IPCA LABORATORIES LTD
- Pack Size: 10 TABLET(s) IN A STRIP
- Dosage Form: TABLET
- Strength: 25MG
- Prescription Required
- Storage: Store at room temperature, between up to 20°C to 25°C (68°F to 77°F) Keep away from moisture, heat, and light. It should not be frozen. Keep away from children and pets.
₹275.00₹324.09
Inclusive of all taxes
Product Introduction
Igurati 25mg Tablet contains iguratimod as its active component. It is indicated for the treatment of rheumatoid arthritis and other autoimmune diseases including ankylosing spondylitis, psoriatic arthritis, systemic lupus erythematosus (SLE), juvenile idiopathic arthritis (JIA), and Behçet's disease. It is an oral disease-modifying antirheumatic drug (DMARD) that reduces inflammation and manages symptoms associated with these conditions. Ankylosing spondylitis is a chronic inflammatory arthritis that primarily affects the spine and pelvis. Psoriatic arthritis is an inflammatory arthritis that can affect joints, skin, and nails, and often occurs in individuals with psoriasis. Systemic Lupus Erythematosus (SLE) is an autoimmune disease affecting various body parts, leading to inflammation, pain, and damage to organs and tissues. Juvenile Idiopathic Arthritis (JIA) is arthritis beginning in childhood, causing joint inflammation and potentially affecting a child's overall health and growth. Behçet's Disease is a rare autoimmune disorder characterised by inflammation affecting various body parts, with symptoms including mouth and genital ulcers, skin lesions, and eye inflammation. Be aware of signs and symptoms of hypersensitivity reactions, including skin rash, hives, itching, swelling (especially of the face, lips, or throat), difficulty breathing, and chest tightness. If you experience any of these symptoms, seek immediate medical attention. Inform your healthcare provider about known allergies, particularly if you have experienced previous hypersensitivity reactions to medications. Igurati 25mg Tablet is contraindicated in individuals with severe hepatic, renal, or significant haematological abnormalities. Avoiding Igurati 25mg Tablet in these cases is important to prevent potential adverse reactions or complications. For children, this medication should be used under the guidance of a paediatric rheumatologist, with careful consideration of dosage, growth monitoring, and open communication with caregivers. For older adults, consultation with a geriatric specialist is crucial to assess potential interactions, adjust dosages, and ensure regular follow-up while emphasising fall prevention, hydration, and nutrition to support safe and effective treatment.
Uses
Igurati 25mg Tablet is used in the following: Rheumatoid arthritis Ankylosing spondylitis Psoriatic arthritis Systemic lupus erythematosus Juvenile idiopathic arthritis Behçet's disease
How it works
Iguratimod's mechanism of action involves suppressing the production of pro-inflammatory cytokines, such as IL-1, IL-6, and TNF-α, which contribute to autoimmune responses and inflammation. It may also modulate T cell activity, downregulate inflammatory mediators like COX-2 and MMPs, and influence immune cell activation, collectively reducing inflammation and mitigating damage caused by autoimmune diseases. Additionally, It's potential antioxidant properties could further contribute to its anti-inflammatory effects.
How to Use
Igurati 25mg Tablet is typically administered orally, which means it is taken by mouth. It is available in the form of tablets or capsules that are ingested with water. Always follow your healthcare provider's instructions regarding the correct dosage, timing, and frequency of administration for this medication.
Side Effects
Igurati 25mg Tablet causes some side effects like all medications, although not everyone will experience them. Serious: Liver Effects Hematologic Effects Allergic Reactions Gastrointestinal Issues Common: Gastrointestinal upset Rash and skin reactions Elevated liver enzymes Upper respiratory tract infections Headache Fatigue
Expert Tips
Be careful for serious allergic reactions, particularly if rash, swelling, or breathing difficulties occur. Pregnant and breastfeeding individuals should avoid Igurati 25mg Tablet. Use caution if you have lung, liver, cardiovascular, or eye conditions, and discuss bone health, immunizations, and mental health with your healthcare provider. Limit alcohol consumption, be cautious with driving and machinery if drowsiness occurs, and protect your skin from sunlight. Communicate pre-existing medical conditions, infections, or surgery plans with your doctor. If you experience unusual symptoms, such as respiratory issues or mood changes, seek prompt medical attention. Follow dosing instructions consistently, attend follow-up appointments, and consult your doctor for personalized guidance based on your health profile.
References
- Huihui Jiang et al; Molecular mechanisms and clinical application of Iguratimod: A review; Biomedicine & Pharmacotherapy; Published on Feb 2020; Accessed on 09/08/2023; https://pubmed.ncbi.nlm.nih.gov/31918275/
- Novartis Pharmaceuticals UK Ltd, Electronic medicines compendium (emc), [Revised on 25th Jul 2022] [Accessed on 9th August 2023], https://www.medicines.org.uk/emc/product/6658/smpc#gref
- Sisi Xie et al; Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape; Frontiers in Pharmacology; Published on 26/02/2020; Accessed on; 09/08/2023 http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7054862/
- Jie Li et al; Iguratimod: a valuable remedy from the Asia Pacific region for ameliorating autoimmune diseases and protecting bone physiology; Bone Research; Published on Sept 2019; Accessed on 09/08/2023; http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6804744/
Safety Advice
Pregnancy: unsafe Igurati 25mg Tablet is not recommended during pregnancy. It is advised to avoid this medication. If you are pregnant or planning to become pregnant, as the safety of the developing fetus has not been established.
Lungs: Consult your doctor If you have lung conditions such as chronic obstructive pulmonary disease (COPD) or interstitial lung disease, consult your healthcare provider before starting Igurati 25mg Tablet.
Breastfeeding: unsafe Igurati 25mg Tablet is not recommended while breastfeeding, as it is unknown if the drug passes into breast milk.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.